vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $86.0M, roughly 2.0× Smart Sand, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.8%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 1.8%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.
ESPR vs SND — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $86.0M |
| Net Profit | — | $1.2M |
| Gross Margin | — | 13.0% |
| Operating Margin | 50.6% | -3.1% |
| Net Margin | — | 1.4% |
| Revenue YoY | 143.7% | -5.8% |
| Net Profit YoY | — | -68.5% |
| EPS (diluted) | $0.32 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $86.0M | ||
| Q3 25 | $87.3M | $92.8M | ||
| Q2 25 | $82.4M | $85.8M | ||
| Q1 25 | $65.0M | $65.6M | ||
| Q4 24 | $69.1M | $91.4M | ||
| Q3 24 | $51.6M | $63.2M | ||
| Q2 24 | $73.8M | $73.8M | ||
| Q1 24 | $137.7M | $83.1M |
| Q4 25 | — | $1.2M | ||
| Q3 25 | $-31.3M | $3.0M | ||
| Q2 25 | $-12.7M | $21.4M | ||
| Q1 25 | $-40.5M | $-24.2M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | $-29.5M | $-98.0K | ||
| Q2 24 | $-61.9M | $-430.0K | ||
| Q1 24 | $61.0M | $-216.0K |
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 16.1% | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 10.3% | ||
| Q2 24 | — | 17.7% | ||
| Q1 24 | — | 14.2% |
| Q4 25 | 50.6% | -3.1% | ||
| Q3 25 | -11.4% | 5.8% | ||
| Q2 25 | 8.6% | -0.1% | ||
| Q1 25 | -34.0% | -10.8% | ||
| Q4 24 | -6.4% | 3.9% | ||
| Q3 24 | -31.0% | -7.8% | ||
| Q2 24 | 3.5% | 4.8% | ||
| Q1 24 | 52.5% | 0.9% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | -35.9% | 3.2% | ||
| Q2 25 | -15.4% | 24.9% | ||
| Q1 25 | -62.2% | -37.0% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | -57.2% | -0.2% | ||
| Q2 24 | -83.9% | -0.6% | ||
| Q1 24 | 44.3% | -0.3% |
| Q4 25 | $0.32 | $0.03 | ||
| Q3 25 | $-0.16 | $0.08 | ||
| Q2 25 | $-0.06 | $0.54 | ||
| Q1 25 | $-0.21 | $-0.62 | ||
| Q4 24 | $-0.14 | $0.10 | ||
| Q3 24 | $-0.15 | $0.00 | ||
| Q2 24 | $-0.33 | $-0.01 | ||
| Q1 24 | $0.34 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $22.6M |
| Total DebtLower is stronger | — | $15.0M |
| Stockholders' EquityBook value | $-302.0M | $239.7M |
| Total Assets | $465.9M | $340.0M |
| Debt / EquityLower = less leverage | — | 0.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $22.6M | ||
| Q3 25 | $92.4M | $5.1M | ||
| Q2 25 | $86.1M | $4.3M | ||
| Q1 25 | $114.6M | $5.1M | ||
| Q4 24 | $144.8M | $1.6M | ||
| Q3 24 | $144.7M | $7.2M | ||
| Q2 24 | $189.3M | $6.3M | ||
| Q1 24 | $226.6M | $4.6M |
| Q4 25 | — | $15.0M | ||
| Q3 25 | — | $14.3M | ||
| Q2 25 | — | $23.5M | ||
| Q1 25 | — | $13.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | — | $15.7M | ||
| Q2 24 | — | $17.1M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $-302.0M | $239.7M | ||
| Q3 25 | $-451.4M | $239.9M | ||
| Q2 25 | $-433.5M | $240.5M | ||
| Q1 25 | $-426.2M | $219.9M | ||
| Q4 24 | $-388.7M | $243.8M | ||
| Q3 24 | $-370.2M | $243.6M | ||
| Q2 24 | $-344.2M | $242.9M | ||
| Q1 24 | $-294.3M | $242.5M |
| Q4 25 | $465.9M | $340.0M | ||
| Q3 25 | $364.0M | $343.1M | ||
| Q2 25 | $347.1M | $345.8M | ||
| Q1 25 | $324.0M | $326.9M | ||
| Q4 24 | $343.8M | $341.5M | ||
| Q3 24 | $314.1M | $335.8M | ||
| Q2 24 | $352.3M | $341.8M | ||
| Q1 24 | $373.1M | $349.3M |
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.06× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.06× | ||
| Q4 24 | — | 0.06× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $22.4M |
| Free Cash FlowOCF − Capex | — | $20.4M |
| FCF MarginFCF / Revenue | — | 23.7% |
| Capex IntensityCapex / Revenue | 0.0% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 18.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $32.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $22.4M | ||
| Q3 25 | $-4.3M | $18.2M | ||
| Q2 25 | $-31.4M | $-5.1M | ||
| Q1 25 | $-22.6M | $8.7M | ||
| Q4 24 | $-35.0M | $1.0M | ||
| Q3 24 | $-35.3M | $5.8M | ||
| Q2 24 | $-7.2M | $14.9M | ||
| Q1 24 | $53.8M | $-3.9M |
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $14.8M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $-840.0K | ||
| Q3 24 | $-35.5M | $3.7M | ||
| Q2 24 | $-7.3M | $13.5M | ||
| Q1 24 | $53.8M | $-5.5M |
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | — | -9.1% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | -68.7% | 5.8% | ||
| Q2 24 | -9.9% | 18.3% | ||
| Q1 24 | 39.0% | -6.6% |
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.0% | 3.1% | ||
| Q1 25 | 0.0% | 5.4% | ||
| Q4 24 | 0.0% | 2.1% | ||
| Q3 24 | 0.3% | 3.4% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | — | 18.99× | ||
| Q3 25 | — | 6.05× | ||
| Q2 25 | — | -0.24× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SND
| Sand | $85.1M | 99% |
| Smart Systems Segment | $980.0K | 1% |
